A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma

Background: Diffuse large B-cell lymphoma (DLBCL) is a genetically heterogeneous disease that can have profound differences in survival outcomes. A variety of powerful prognostic factors and models have been constructed; however, the development of more accurate prognosis prediction and targeted tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hong, Li, Yuhang, Jiang, Yanan, Wang, Jinhuan, Sun, Huimeng, Wu, Wenqi, LV, Yangyang, Liu, Su, Zhai, Yixin, Tian, LinYan, Li, Lanfang, Zhao, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237400/
https://www.ncbi.nlm.nih.gov/pubmed/35774514
http://dx.doi.org/10.3389/fgene.2022.827840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237400/
https://www.ncbi.nlm.nih.gov/pubmed/35774514
http://dx.doi.org/10.3389/fgene.2022.827840

Ejemplares similares